Cite

HARVARD Citation

    Zhang, N. et al. (2022). UBE3A deletion enhances the efficiency of immunotherapy in non-small-cell lung cancer. Bioengineered. 13 (5), pp. 11577-11592. [Online]. 
  
Back to record